Filing Details

Accession Number:
0001014108-22-000010
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-01-04 21:16:13
Reporting Period:
2021-12-30
Accepted Time:
2022-01-04 21:16:13
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1337013 Infusystem Holdings Inc INFU Surgical & Medical Instruments & Apparatus (3841) 203341405
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1775188 Jeannine Sheehan 3851 West Hamlin Road
Rochester Hill MI 48309
Chief Administrative Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-12-30 1,000 $4.48 18,607 No 4 M Direct
Common Stock Disposition 2021-12-30 1,000 $17.00 17,607 No 4 S Direct
Common Stock Acquisiton 2021-12-31 6,943 $4.48 24,550 No 4 M Direct
Common Stock Disposition 2021-12-31 6,943 $17.01 17,607 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2021-12-30 1,000 $0.00 1,000 $4.48
Common Stock Stock Option (right to buy) Disposition 2021-12-31 6,943 $0.00 6,943 $4.48
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
41,539 2020-04-22 2024-04-22 No 4 M Direct
34,596 2020-04-22 2024-04-22 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 345 Indirect By Children
Footnotes
  1. The price reported in Column 4 is a weighted average price. The shares reported herein were sold in multiple transactions. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
  2. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.